Article

Social activity in older persons slows motor function decline

In older persons who do not have dementia, stroke, or Parkinson disease, a lower frequency of participation in social activity is associated with more rapid motor function decline. Conversely, participation in a broad spectrum of late-life activities results in positive health outcomes.

In older persons who do not have dementia, stroke, or Parkinson disease, a lower frequency of participation in social activity is associated with more rapid motor function decline. Conversely, participation in a broad spectrum of late-life activities results in positive health outcomes.

Buchman and colleagues collected data from 906 participants in the Rush Memory and Aging Project. Older persons were assigned a social activity score based on how often they participated in 6 common social activities, such as volunteering or playing bingo. They also were asked how often they performed physical and cognitive activities, and they were evaluated for disability.

The most socially active participants had the best motor function. The association was strong: for each 1-point drop in social activity, motor function declined 33% faster than normal and the risk of death increased by more than 40%. The incidence of disability also escalated significantly as social activity waned. The net effect on the person was equivalent to aging 5 years. This relationship persisted, regardless of demographics.

The authors noted that public health interventions that emphasize leisure activities might help older persons stay healthier and reduce the burden of eldercare on society.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.